CAAIF: Allergic Airways Disease Innovation Grant
Research Admin Offices:
There are three awards available for a maximum value of $85,000 each for a duration of one year.
Internal Deadline:January 2, 2023
Sponsor Deadline:January 16, 2023
The objective of the Allergic Airways Disease Innovation Grant is to fund innovative research of a “high-risk, high-reward” nature that will have impact on the prevention or treatment of allergic airways disease.
These awards are sponsored by CIHR-Institute of Circulatory and Respiratory Health, AstraZeneca Canada and CAAIF.
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.